Patients Sue Genzyme Over Fabrazyme Rationing
By Megan Stride ( March 11, 2011, 1:57 PM EST) -- A group of patients slapped Genzyme Corp. with a putative national class action in Pennsylvania on Wednesday over the rationing plan it implemented for its enzyme replacement drug Fabrazyme after safety violations at its manufacturing plant forced it to cut production....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.